drugset / Trial / NCT00245661

Effects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease

NCT00245661

Phase 3 Completed 14 enrolled Rijnstate Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of temazepam during sleep and in daytime on dyspnea, gas exchange and sleep quality in patients with chronic obstructive pulmonary disease. The study hypothesis is that temazepam does not produce any adverse respiratory effects during sleep in patients with COPD. In contrast, it may result in an beneficiary effect because it positively affects the sleep quality and sleep structure which may result in more alertness and less daytime sleepiness and less dyspnea during the day.

Timeline

Start
2005-10
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Temazepam Small molecule 10 mg